Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00388622 · ClinicalTrials.gov registry record · NA
Improving Drug Use for Elderly Heart Failure Patients
A NA study, sponsored by University of North Carolina.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
NCT00388622: Completed NA study, sponsored by University of North Carolina.
NCT00388622 is a NA study that has completed, run by University of North Carolina. The registered enrollment target is 314 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00388622, a NA study, has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
Study Summary
The aims of this randomized, clinical trial are to develop and test a multileveled pharmacy-based program to improve the care of patients with heart failure. Risk factors for deterioration of heart failure will be determined including poor adherence to medication.
Interventions
- BEHAVIORAL Pharmacist intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2001-02 |
| Est. Completion | 2004-11 |
| Phase | NA |
What the finished NCT00388622 record still lists
NCT00388622 is an interventional study that assigns participants to a tested intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Pharmacist intervention is the first listed.
NCT00388622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00388622 about?
NCT00388622 is a clinical study titled "Improving Drug Use for Elderly Heart Failure Patients". The aims of this randomized, clinical trial are to develop and test a multileveled pharmacy-based program to improve the care of patients with heart failure. Risk factors for deterioration of heart failure will be determined including poor adherence to medication.
What is the current status of trial NCT00388622?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2001-02. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00388622?
The interventions under investigation include: Pharmacist intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00388622?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00388622's enrollment target sits among peer trials
314 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
- NCT06883097 · 314 participants · NA
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia